Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Jaguar Health (JAGX) Gross Margin (2016 - 2025)

Historic Gross Margin for Jaguar Health (JAGX) over the last 11 years, with Q3 2025 value amounting to 35.23%.

  • Jaguar Health's Gross Margin fell 1000.0% to 35.23% in Q3 2025 from the same period last year, while for Sep 2025 it was 17.93%, marking a year-over-year decrease of 199700.0%. This contributed to the annual value of 34.19% for FY2024, which is 3800.0% up from last year.
  • Per Jaguar Health's latest filing, its Gross Margin stood at 35.23% for Q3 2025, which was down 1000.0% from 17.19% recorded in Q2 2025.
  • Jaguar Health's Gross Margin's 5-year high stood at 47.67% during Q3 2023, with a 5-year trough of 469.09% in Q2 2021.
  • Over the past 5 years, Jaguar Health's median Gross Margin value was 26.6% (recorded in 2022), while the average stood at 21.35%.
  • Its Gross Margin has fluctuated over the past 5 years, first tumbled by -5144700bps in 2021, then skyrocketed by 4956900bps in 2022.
  • Quarter analysis of 5 years shows Jaguar Health's Gross Margin stood at 10.48% in 2021, then surged by 543bps to 46.38% in 2022, then dropped by -28bps to 33.43% in 2023, then plummeted by -32bps to 22.63% in 2024, then surged by 56bps to 35.23% in 2025.
  • Its Gross Margin was 35.23% in Q3 2025, compared to 17.19% in Q2 2025 and 12.6% in Q1 2025.